RDY logo

RDY
Dr. Reddy's Laboratories Ltd.

618
Mkt Cap
$11.32B
Volume
723,654.00
52W High
$16.17
52W Low
$12.19
PE Ratio
23.14
RDY Fundamentals
Price
$13.60
Prev Close
$13.55
Open
$13.55
50D MA
$13.47
Beta
0.41
Avg. Volume
2.63M
EPS (Annual)
$0.5826
P/B
2.74
Rev/Employee
$136,706.91
$10,916.67
Loading...
Loading...
News
all
press releases
Dr. Reddy's Laboratories Launches its Generic Semaglutide Injection in Canada
Dr. Reddys Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; along with its subsidiaries together referred to as Dr. Reddys), a global pharmaceutical company, today announced...
News Placeholder
More News
News Placeholder
Dr. Reddy's Q4 Earnings and Revenues Miss Estimates, Stock Down
RDY stock down 5% on missing fiscal fourth-quarter 2026 earnings and revenue estimates as North America generics sales slumped.
News Placeholder
Dr. Reddy's Laboratories (RDY) to Release Earnings on Tuesday
Dr. Reddy's Laboratories (NYSE:RDY) will be releasing its Q4 25/26 earnings before the market opens on Tuesday, May 12. (View Earnings Report at...
News Placeholder
Aikya Investment Management Ltd Has $103.03 Million Position in Dr. Reddy's Laboratories Ltd $RDY
Aikya Investment Management Ltd grew its holdings in shares of Dr. Reddy's Laboratories Ltd (NYSE:RDY - Free Report) by 9.3% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 7,338,525 shares of the...
News Placeholder
AMPH vs. RDY: Which Stock Should Value Investors Buy Now?
AMPH vs. RDY: Which Stock Is the Better Value Option?
News Placeholder
Dr. Reddy's Laboratories Announces Health Canada Approval for Generic Semaglutide Injection in Canada
Dr. Reddys Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; along with its subsidiaries together referred to as Dr. Reddys), a global pharmaceutical company, today announced...
News Placeholder
AMRX Valuation: What 1.69x Sales Means for Investors
Amneal trades at 1.69x sales, below sector benchmarks, as investors weigh raised 2026 profit guidance against Specialty pressure and launch execution.
News Placeholder
Dr. Reddy's Laboratories Ltd $RDY Shares Acquired by B. Metzler seel. Sohn & Co. AG
B. Metzler seel. Sohn & Co. AG increased its holdings in Dr. Reddy's Laboratories Ltd (NYSE:RDY - Free Report) by 912.6% during the fourth quarter, according to its most recent filing with the...
News Placeholder
Dr. Reddy's Laboratories (NYSE:RDY) Rating Lowered to Sell at The Goldman Sachs Group
The Goldman Sachs Group downgraded shares of Dr. Reddy's Laboratories from a "neutral" rating to a "sell" rating in a report on Thursday...
News Placeholder
Dr. Reddy's Laboratories (NYSE:RDY) Shares Gap Up - Here's What Happened
Dr. Reddy's Laboratories (NYSE:RDY) Shares Gap Up - Here's What Happened...
<
1
2
...
>

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available